JP2017066148A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017066148A5 JP2017066148A5 JP2016217326A JP2016217326A JP2017066148A5 JP 2017066148 A5 JP2017066148 A5 JP 2017066148A5 JP 2016217326 A JP2016217326 A JP 2016217326A JP 2016217326 A JP2016217326 A JP 2016217326A JP 2017066148 A5 JP2017066148 A5 JP 2017066148A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- dextran
- dtpa
- composition
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/362,778 US20100196272A1 (en) | 2009-01-30 | 2009-01-30 | Compositions for radiolabeling diethylenetriaminepentaacetic acid (dtpa)-dextran |
| US12/362,778 | 2009-01-30 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015090380A Division JP6040276B2 (ja) | 2009-01-30 | 2015-04-27 | ジエチレントリアミン五酢酸（ｄｔｐａ）−デキストランを放射標識するための組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019071387A Division JP6833892B2 (ja) | 2009-01-30 | 2019-04-03 | ジエチレントリアミン五酢酸（ｄｔｐａ）−デキストランを放射標識するための組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017066148A JP2017066148A (ja) | 2017-04-06 |
| JP2017066148A5 true JP2017066148A5 (OSRAM) | 2017-06-15 |
| JP6509796B2 JP6509796B2 (ja) | 2019-05-08 |
Family
ID=42395938
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011547973A Expired - Fee Related JP5743905B2 (ja) | 2009-01-30 | 2010-01-28 | ジエチレントリアミン五酢酸（ｄｔｐａ）−デキストランを放射標識するための組成物 |
| JP2015090380A Active JP6040276B2 (ja) | 2009-01-30 | 2015-04-27 | ジエチレントリアミン五酢酸（ｄｔｐａ）−デキストランを放射標識するための組成物 |
| JP2016217326A Expired - Fee Related JP6509796B2 (ja) | 2009-01-30 | 2016-11-07 | ジエチレントリアミン五酢酸（ｄｔｐａ）−デキストランを放射標識するための組成物 |
| JP2019071387A Expired - Fee Related JP6833892B2 (ja) | 2009-01-30 | 2019-04-03 | ジエチレントリアミン五酢酸（ｄｔｐａ）−デキストランを放射標識するための組成物 |
| JP2021015866A Withdrawn JP2021088566A (ja) | 2009-01-30 | 2021-02-03 | ジエチレントリアミン五酢酸（ｄｔｐａ）−デキストランを放射標識するための組成物 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011547973A Expired - Fee Related JP5743905B2 (ja) | 2009-01-30 | 2010-01-28 | ジエチレントリアミン五酢酸（ｄｔｐａ）−デキストランを放射標識するための組成物 |
| JP2015090380A Active JP6040276B2 (ja) | 2009-01-30 | 2015-04-27 | ジエチレントリアミン五酢酸（ｄｔｐａ）−デキストランを放射標識するための組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019071387A Expired - Fee Related JP6833892B2 (ja) | 2009-01-30 | 2019-04-03 | ジエチレントリアミン五酢酸（ｄｔｐａ）−デキストランを放射標識するための組成物 |
| JP2021015866A Withdrawn JP2021088566A (ja) | 2009-01-30 | 2021-02-03 | ジエチレントリアミン五酢酸（ｄｔｐａ）−デキストランを放射標識するための組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US20100196272A1 (OSRAM) |
| EP (2) | EP2392012B1 (OSRAM) |
| JP (5) | JP5743905B2 (OSRAM) |
| KR (2) | KR101765717B1 (OSRAM) |
| CN (1) | CN102301429A (OSRAM) |
| AU (1) | AU2010208624B2 (OSRAM) |
| BR (1) | BRPI1007487A2 (OSRAM) |
| CA (1) | CA2750230C (OSRAM) |
| WO (1) | WO2010087959A1 (OSRAM) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100196272A1 (en) * | 2009-01-30 | 2010-08-05 | Neoprobe Corporation | Compositions for radiolabeling diethylenetriaminepentaacetic acid (dtpa)-dextran |
| JP6163698B2 (ja) * | 2013-03-21 | 2017-07-19 | 国立大学法人 千葉大学 | マクロファージマンノース受容体を認識する新規多糖金属錯体化合物、及び、その医薬組成物 |
| EP3024493A1 (en) | 2013-07-22 | 2016-06-01 | Navidea Biopharmaceuticals, Inc. | Compositions, methods and kits for diagnosing and treating cd206 expressing cell-related disorders |
| US10328149B2 (en) | 2014-06-13 | 2019-06-25 | Tenboron Oy | Conjugates comprising an anti-EGFR1 antibody |
| CA2955438C (en) * | 2014-07-17 | 2024-07-02 | Ohio State Innovation Foundation | DEXTRANE CONJUGATES TO TARGET MACROPHAGES AND OTHER CELLS EXPRESSING THE D-MANBOSE BINDING TYPE C LECTIN RECEPTOR |
| US10806803B2 (en) | 2014-07-17 | 2020-10-20 | Ohio State Innovation Foundation | Compositions for targeting macrophages and other CD206 high expressing cells and methods of treating and diagnosis |
| CN115536714B (zh) * | 2014-11-13 | 2026-04-24 | 沃特世科技公司 | 快速标记的n-聚糖的液相色谱校准方法 |
| GB201504064D0 (en) | 2015-03-10 | 2015-04-22 | Accretion Biotechnology Ltd | Method and kits for preparing radionuclide complexes |
| CN106317237B (zh) * | 2015-07-03 | 2019-07-19 | 华中科技大学 | 一种用于spect成像的当归多糖衍生物及其合成方法 |
| CN106188226B (zh) * | 2016-07-04 | 2019-12-24 | 江苏省原子医学研究所 | 一种用于淋巴结检查的大分子显像剂及其制备方法 |
| US10695450B2 (en) | 2016-07-26 | 2020-06-30 | Laboratoires Cyclopharma | Synthesis of a radioactive agent composition |
| FR3054445B1 (fr) * | 2016-07-26 | 2019-07-05 | Laboratoires Cyclopharma | Synthese d'une composition d'agent radioactif |
| IL265846B2 (en) | 2016-10-07 | 2024-02-01 | Navidea Biopharmaceuticals Inc | Compounds and methods for diagnosis and treatment of viral infections |
| JP6329302B2 (ja) * | 2017-05-10 | 2018-05-23 | 国立大学法人千葉大学 | マクロファージマンノース受容体を認識する新規多糖金属錯体化合物、及び、その医薬組成物 |
| US20220175973A1 (en) * | 2019-03-29 | 2022-06-09 | National Institutes for Quantum Science and Technology | Method for producing radiopharmaceutical and radiopharmaceutical |
| CA3168879A1 (en) | 2020-07-08 | 2022-01-13 | Navidea Biopharmaceuticals, Inc. | Synthesis of uniformly defined molecular weight mannosylated dextrans and derivatives thereof |
| WO2023225273A1 (en) | 2022-05-20 | 2023-11-23 | Navidea Biopharmaceuticals, Inc. | Cd206 targeted drug delivery vehicles carrying novel bisphosphonate drug payloads via a degradable linker |
| JP2025535006A (ja) | 2022-10-03 | 2025-10-22 | ナビディア、バイオファーマスーティカルズ、インコーポレイテッド | 炭水化物ポリマーに結合されたアミン終端リーシュへの糖部分のアミド結合 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1053508B (it) * | 1970-07-06 | 1981-10-10 | Searle & Co | Procedimento per prepare composizioni marcate adatte a mettere in evidenza alterazioni della mucosa gastrointestinale prodotto ottenuto e relativo metodo di impiego |
| US4364920A (en) * | 1975-04-30 | 1982-12-21 | Medi-Physics, Inc. | Stable diagnostic reagents |
| US4048296A (en) * | 1975-05-27 | 1977-09-13 | Mallinckrodt, Inc. | Radiopharmaceutical scanning agents |
| JPS5569517A (en) * | 1978-11-20 | 1980-05-26 | Nippon Mejifuijitsukusu Kk | Labelling preparation for labelling of erythrocytes with radio-active technetium |
| SE465907B (sv) | 1984-11-01 | 1991-11-18 | Nyegaard & Co As | Diagnosticeringsmedel innehaallande en paramagnetisk metall |
| US5336762A (en) | 1985-11-18 | 1994-08-09 | Access Pharmaceuticals, Inc. | Polychelating agents for image and spectral enhancement (and spectral shift) |
| US4822594A (en) | 1987-01-27 | 1989-04-18 | Gibby Wendell A | Contrast enhancing agents for magnetic resonance images |
| CS263561B1 (en) | 1987-09-18 | 1989-04-14 | Kery Vladimir | Process for preparing water soluble allylderivatives of oligo and polysaccharides |
| GB8801646D0 (en) * | 1988-01-26 | 1988-02-24 | Nycomed As | Chemical compounds |
| US5328679A (en) * | 1988-04-01 | 1994-07-12 | Immunomedics, Inc. | Methods for technetium/rhenium labeling of proteins |
| DD286598A5 (de) | 1989-06-29 | 1991-01-31 | Adw Der Ddr,Zi F. Mulekularbiologie,De | Verfahren zur einfuehrung von primaeren aminogruppen in wasserloesliche polymere |
| EP0516873A1 (en) * | 1991-06-06 | 1992-12-09 | THE STATE of ISRAEL Atomic Energy Commission Soreq Nuclear Research Center | A method and kit for protein labelling with 99 mTC |
| US5789578A (en) | 1996-01-11 | 1998-08-04 | Massey University | Methods for the preparation of resins with ligands attached thereto through a linking group comprising sulfide, sulfoxide or sulfone functionality |
| WO1997028181A2 (en) * | 1996-02-02 | 1997-08-07 | Rhomed Incorporated | Post-labeling stabilization of radiolabeled proteins and peptides |
| US20010055563A1 (en) * | 1999-09-09 | 2001-12-27 | Rhomed Incorporated | Post-labeling stabilization of radiolabeled proteins and peptides |
| US6066309A (en) * | 1996-02-02 | 2000-05-23 | Rhomed Incorporated | Post-labeling stabilization of radiolabeled proteins and peptides |
| WO1998023293A1 (en) | 1996-11-28 | 1998-06-04 | Nihon Schering K.K. | Contrast compound, contrast medium for mri, and method for mri |
| ATE277642T1 (de) * | 1999-05-14 | 2004-10-15 | Univ California | Makromolekular träger auf basis von dextran fur arzneimittel und diagnosticum abgabe |
| US6887462B2 (en) * | 2001-04-09 | 2005-05-03 | Chiron Corporation | HSA-free formulations of interferon-beta |
| US7666979B2 (en) | 2002-03-01 | 2010-02-23 | Bracco International B.V. | Methods for preparing multivalent constructs for therapeutic and diagnostic applications and methods of preparing the same |
| NZ536475A (en) * | 2002-05-24 | 2008-06-30 | Schering Corp | Neutralizing human anti-igfr antibody |
| EP2284180B1 (en) | 2003-03-03 | 2015-09-09 | Dyax Corp. | Uses of peptides that specifically bind HGF receptor (cMET) |
| KR101188691B1 (ko) * | 2004-10-29 | 2012-10-09 | 파르마 마르 에스.에이. | 엑티나시딘 및 디사카라이드를 포함하는 제제 |
| TWI398272B (zh) * | 2005-03-08 | 2013-06-11 | Intervet Int Bv | 化學定義的安定劑 |
| EP1933867A1 (en) * | 2005-10-04 | 2008-06-25 | Alk-Abello A/S | Solid vaccine formulation |
| AU2007234612B2 (en) * | 2006-12-14 | 2013-06-27 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein stabilization formulations |
| ATE512660T1 (de) * | 2007-03-05 | 2011-07-15 | Cadila Healthcare Ltd | Zusammensetzungen mit peg-interferon-alpha- konjugaten und raffinose als kryoschutzmittel |
| US20100196272A1 (en) | 2009-01-30 | 2010-08-05 | Neoprobe Corporation | Compositions for radiolabeling diethylenetriaminepentaacetic acid (dtpa)-dextran |
| EP3024493A1 (en) | 2013-07-22 | 2016-06-01 | Navidea Biopharmaceuticals, Inc. | Compositions, methods and kits for diagnosing and treating cd206 expressing cell-related disorders |
| CA2955438C (en) | 2014-07-17 | 2024-07-02 | Ohio State Innovation Foundation | DEXTRANE CONJUGATES TO TARGET MACROPHAGES AND OTHER CELLS EXPRESSING THE D-MANBOSE BINDING TYPE C LECTIN RECEPTOR |
| EP3169336A4 (en) | 2014-07-17 | 2018-04-04 | Ohio State Innovation Foundation | Compositions for targeting macrophages and other cd206 high expressing cells and methods of treating and diagnosis |
-
2009
- 2009-01-30 US US12/362,778 patent/US20100196272A1/en not_active Abandoned
-
2010
- 2010-01-28 EP EP10736135.4A patent/EP2392012B1/en active Active
- 2010-01-28 AU AU2010208624A patent/AU2010208624B2/en not_active Ceased
- 2010-01-28 KR KR1020177005797A patent/KR101765717B1/ko not_active Expired - Fee Related
- 2010-01-28 WO PCT/US2010/000222 patent/WO2010087959A1/en not_active Ceased
- 2010-01-28 EP EP21152405.3A patent/EP3884965A1/en not_active Withdrawn
- 2010-01-28 JP JP2011547973A patent/JP5743905B2/ja not_active Expired - Fee Related
- 2010-01-28 CA CA2750230A patent/CA2750230C/en active Active
- 2010-01-28 CN CN2010800062510A patent/CN102301429A/zh active Pending
- 2010-01-28 KR KR1020117020202A patent/KR101713559B1/ko not_active Expired - Fee Related
- 2010-01-28 BR BRPI1007487A patent/BRPI1007487A2/pt not_active IP Right Cessation
-
2012
- 2012-05-01 US US13/461,306 patent/US8545808B2/en active Active
-
2013
- 2013-09-27 US US14/039,648 patent/US9439985B2/en active Active
-
2015
- 2015-04-27 JP JP2015090380A patent/JP6040276B2/ja active Active
-
2016
- 2016-08-10 US US15/233,144 patent/US20160347679A1/en not_active Abandoned
- 2016-11-07 JP JP2016217326A patent/JP6509796B2/ja not_active Expired - Fee Related
-
2019
- 2019-04-03 JP JP2019071387A patent/JP6833892B2/ja not_active Expired - Fee Related
-
2021
- 2021-02-03 JP JP2021015866A patent/JP2021088566A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015164933A5 (OSRAM) | ||
| JP6833892B2 (ja) | ジエチレントリアミン五酢酸（ｄｔｐａ）−デキストランを放射標識するための組成物 | |
| US9211341B2 (en) | Method of manufacturing a pharmaceutical composition having chelating type complex micelles | |
| HRP20231504T1 (hr) | Polisaharidi kapsule iz bakterije streptococcus pneumoniae i njihovi konjugati | |
| HRP20212027T1 (hr) | Formulacije polialkilen oksidne asparaginaze i postupci njihove priprave i uporabe | |
| JP2012532185A5 (OSRAM) | ||
| JP2013543505A5 (OSRAM) | ||
| JP2021505661A5 (OSRAM) | ||
| US10632081B2 (en) | Intralymphatic delivery of hyaluronan nanoparticle for cancer metastasis | |
| FI3817751T3 (fi) | Vedettömän natriumtiosulfaatin formulaatioita | |
| JP2020520368A5 (OSRAM) | ||
| JP2019512012A5 (OSRAM) | ||
| JP2016512210A5 (OSRAM) | ||
| JP2019521179A5 (OSRAM) | ||
| HRP20201683T1 (hr) | Imunogeni pripravak namijenjen upotrebi u terapiji | |
| JP2021513521A5 (OSRAM) | ||
| HRP20230989T1 (hr) | Novi sastavi željeza i metode njihove izrade i upotrebe | |
| Kobayashi et al. | Pharmacokinetic study of weekly administration dose of paclitaxel in patients with advanced or recurrent gastric cancer in Japan | |
| JP5340964B2 (ja) | 腫瘍細胞に対する殺傷効果を備えた修飾されたヒドロキシポリマーコンジュゲート | |
| FI3554474T3 (fi) | Mikafungiinikoostumuksia | |
| US20140072604A1 (en) | Block Copolymer For Intraperitoneal Administration Containing Anti-Cancer Agent, Micelle Preparation Thereof, And Cancer Therapeutic Agent Comprising The Micelle Preparation As Active Ingredient | |
| JP2014504613A5 (OSRAM) | ||
| MX2007009312A (es) | Preparaciones inyectables de diclofenaco y sus sales farmaceuticamente aceptables. | |
| JP2021520344A5 (OSRAM) | ||
| HRP20201475T1 (hr) | Uporaba neridronske kiseline ili njene soli za liječenje osteoartroze |